ML
MLC.IR Malin Corporation plc
- Market cap
- EUR 25.7M
- P/E
- -
- P/B
- 0.13x
- ROE
- 0.0%
- Dividend yield
- -
- Fundamental score
- 1.1/5
Ratios use the latest price and the fiscal year ending Dec 2024.
Is MLC.IR undervalued?
Graham numberThe Graham number of Malin Corporation plc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Malin Corporation plc fundamental analysis
5 of 21 checks passedROE 0/2
Low return on equity (0.0%), below 10%.
ROA 0/1
Return on assets (0.0%) is below the industry median (3.8%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 0/1
Earnings growth cannot be compared with the industry.
Revenue Growth 0/2
Revenue did not grow over the past 3 years or is not reported.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 0/2
Debt to equity cannot be calculated: debt is not reported or equity is negative.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Cash Runway 2/2
Cash covers 47.8 years of the current cash burn.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 1/1
Price to book (0.1x) is below the industry median (1.5x).
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Malin Corporation plc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Malin Corporation plc
Malin Corporation plc, together with its subsidiaries, operates as an investment company in Europe and North America. It engages in the investment in life sciences and healthcare companies targeting various therapeutic areas, including oncology, immunology, and genetic diseases. The company was incorporated in 2014 and is headquartered in Dublin, Ireland.
Full company profileMalin Corporation plc financial statements
Malin Corporation plc annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 22.9M | 42.1M | 41.9M | 38.0M | 34.9M | 41.0M | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 3.60M | 11.5M | 11.1M | 4.10M | 7.50M | 10.2M | - | - | - | - |
| Operating Income | -27.0M | -46.5M | -45.3M | -23.3M | -14.0M | -8.90M | -2.60M | -700K | -3.90M | -2.50M |
| EBITDA | -41.7M | -76.2M | -91.6M | -39.1M | 1.70M | 100M | 2.70M | 12.8M | 400K | 300K |
| Net Income | -44.9M | -83.5M | -98.8M | -46.3M | -5.40M | 87.7M | 37.8M | 12.9M | 0.00 | 0.00 |
| EPS | -1.63 | -2.12 | -2.36 | -1.01 | -0.12 | 1.89 | 0.82 | 0.37 | 0.00 | 0.00 |
| Balance Sheet | ||||||||||
| Total Assets | 424M | 403M | 308M | 264M | 272M | 371M | 228M | 288M | 117M | 199M |
| Total Liabilities | 58.8M | 94.8M | 86.6M | 94.0M | 92.7M | 80.5M | 9.30M | 4.80M | 7.10M | 5.30M |
| Shareholders' Equity | 349M | 286M | 207M | 161M | 169M | 280M | 219M | 283M | 110M | 193M |
| Cash & Short-term Investments | 97.0M | 46.9M | 27.1M | 48.8M | 28.2M | 17.5M | 32.7M | 174M | 29.3M | 62.1M |
| Total Debt | 34.9M | 67.6M | 63.5M | 73.0M | 69.6M | 56.4M | 100K | - | - | - |
| Cash Flow | ||||||||||
| Operating Cash Flow | -17.0M | -22.4M | -27.2M | -13.4M | -4.10M | -3.00M | -4.60M | -7.20M | -3.20M | -1.30M |
| Capital Expenditure | 800K | 3.10M | 4.20M | 4.90M | 2.80M | 2.10M | 1.60M | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | -17.8M | -25.5M | -31.4M | -18.3M | -6.90M | -5.10M | -6.20M | -7.20M | -3.20M | -1.30M |
| Ratios | ||||||||||
| ROE | -12.9% | -29.2% | -47.7% | -28.8% | -3.2% | 31.3% | 17.3% | 4.6% | 0.0% | 0.0% |
| ROA | -10.6% | -20.7% | -32.1% | -17.5% | -2.0% | 23.7% | 16.6% | 4.5% | 0.0% | 0.0% |
| Net Profit Margin | -196.1% | -198.3% | -235.8% | -121.8% | -15.5% | 213.9% | - | - | - | - |
| Debt to Equity | 0.10x | 0.24x | 0.31x | 0.45x | 0.41x | 0.20x | 0.00x | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Malin Corporation plc dividends
Malin Corporation plc has not paid dividends in the last 10 fiscal years.
Who owns Malin Corporation plc
- Insiders 34.96%
- Institutions 44.29%
- Public & others 20.75%
- Shares outstanding 4.33M
- Free float 893K
Malin Corporation plc company profile
- Company name
- Malin Corporation plc
- Ticker
- MLC.IR
- ISIN
- IE00BVGC3741
- Exchange
- Irish Exchange
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Employees
- 2
- Fiscal year end
- December
- Address
- The Lennox Building, Dublin, Ireland, D02 FK02
- Phone
- 353 1 905 3531
- Website
- malinplc.com
About Malin Corporation plc
Malin Corporation plc, together with its subsidiaries, operates as an investment company in Europe and North America. It engages in the investment in life sciences and healthcare companies targeting various therapeutic areas, including oncology, immunology, and genetic diseases. The company was incorporated in 2014 and is headquartered in Dublin, Ireland.
Malin Corporation plc management
2- Mr. William F. DanielExecutive Chair · born 1952
- Andrea StaffordHead of Finance & Company Secretary